Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort

This publication has 25 references indexed in Scilit:

• Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of Clopidogrel
  Circulation, 2005
• Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention
  Circulation, 2005
• Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets
  Circulation, 2005
• High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability
  European Heart Journal, 2004
• Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation
  Journal of the American College of Cardiology, 2004
• Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting
  Thrombosis Research, 2003
• Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
  JAMA, 2002
• Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
  New England Journal of Medicine, 2001
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
  The Lancet, 2001
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996